Dr. Pelles Sharon is a distinguished oncologist with expertise in various cancer treatments. Her contributions to clinical research include a study on oncologic patients' understanding and attitudes towards clinical trials.
Transfer to the hospital
OncoSil™ is an innovative treatment for patients with non-operable pancreatic cancer. It is defined as a breakthrough technology by the US Food and Drug Administration (FDA), and in combination with chemotherapy has shown a significant reduction in tumor size. Endoscopic Ultrasound Guidance: The OncoSil™ device is administered via endoscopic ultrasound guidance. This approach allows for real-time visualization and accurate placement of the microparticles within the tumor.
Personal medical coordinator
Medical travel arrangements — booking of air tickets and hotel rooms at special partner prices
Patient advocacy during medical travel